An interventional study of Face-to-face standard treatment and Telematic Support in High-risk Infants, sponsored by Universidad de Granada. Enrolling by invitation at 1 site in Spain. Open to participants aged 3 Months to 12 Months. Per ClinicalTrials.gov, last updated 2024-09-23.
Sponsored by Universidad de Granada · Not applicable, Interventional, and Supportive care
The purpose of this study is to evaluate the effects of early intervention support sessions via video conferencing as an adjuvant option to motor development on infants at risk of neurodevelopmental delays or disorders.
The parents will be informed about the procedure and will be given a written informed consent in order to participate in the study. Then, the families will be randomized into one of two groups: standard treatment or telematic support. Both treatments in a 2-month period.
Universidad de Granada is the lead sponsor of 241 studies on the registry; 41 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
participants will receive face-to-face early intervention treatment on physical therapy area once a month for two months.
Other: Face-to-face standard treatment
Participants will receive weekly telematic early intervention sessions at home via video conferencing for two months.
Other: Telematic Support
Individualized early intervention treatment on physical therapy area as usual in the early intervention facilities once a month for two months. Instructions will be given to the parents for follow-up at home to stimulate the baby's motor development until next face-to-face session.
The physiotherapist in charge of the telematic sessions will review and guide in real time through WhatsApp platform, the performance and active participation of the parents in the therapeutic activities being asked to follow-up at home in the face-to-face appointment, correcting, as necessary.
Change from Baseline in Motor Development on the Motor scale of the Infant Motor Development on the Bayley Scales of Infant and Toddler Development-III® (BSID-III) at month 2.
The BSID-III is an assessment tool for diagnosing developmental delays in early childhood from 1 to 42 months. It assesses 5 developmental domains: Cognitive Scale, Language Scale, Motor scale, Social-Emotional Scale and Adaptative Scale. The motor scale has 66 items in the fine motor and 72 items in the gross motor domain which are administrated according to the child development. Change= (2 months development score - baseline Score).
Time frame: Baseline and Month 2.
Change from Baseline in maturation of motor skills on the Alberta Infant Motor Scale (AIMS) at month 2.
The AIMS is an observational assessment tool that requires minimal handling of an infant by the examiner. It assesses the maturation of infant's motor skills from term (40 weeks gestation) to 18 months. It has 58 observational items divided into four subscales which are prone, supine, sitting and standing. Change= (2 months development score - baseline Score).
Time frame: Baseline and Month 2.
Change from Baseline in infant motor behaviour and motor development on the Infant Motor Profile (IMP) at month 2.
The IMP is a video-based assessment for infants aged 3 to 18 months. It assesses the spontaneous motor behaviour in supine, prone, sitting, standing, walking and during reaching and grasping - depending on the age of the infant. Includes 5 domains: the size of the infant's motor repertoire, the infant's ability to make an adaptive selection out of his/her repertoire, performance, symmetry and fluency. Change= (2 months IMP total and subscales scores - baseline scores).
Time frame: Baseline and Month 2.
Change from Baseline in parents' quality of life on the Care-related quality of life (CarerQol) at month 2.
CarerQol measures the impact of providing informal care on caregivers. Consists of seven items questionnaire to evaluate the impact of informal care on satisfaction, support, problems with daily activities, and financial, relational, mental health and physical health problems of caregivers, and a Visual Analogue Scale which measures general well-being in terms of happiness from 0 (completely unhappy) to 10 (completely happy). Change= (2 months scores on each item - baseline Score).
Time frame: Baseline and Month 2.
Change from Baseline in levels of stress experienced by parents on the Parental Stress Scale (PSS) at month 2.
The Paretal Stress Scale is an 18-item self-report measure design to assess the perceived levels of stress resulting from being a parent. Overall possible scores on the scale range from 18 to 90 with higher scores indicating a higher level of stress. There are no average scores or "cut-off's" for this tool. Change= (2 months stress score - baseline score).
Time frame: Baseline and Month 2.
Parents satisfaction with the telematic support service measured with the Client Satisfaction Questionnaire (CSQ-8).
The Client Satisfaction Questionnaire is an 8-item measure of client or consumer satisfaction with health and human services including governmental and public benefit programs and services. Overall possible scores on the scale range from 8 to 32 with higher scores indicating a higher level of satisfaction with the given service. There are no average scores or "cut-off's" for this tool.
Time frame: Month 2
Change from Baseline in parental self-efficacy and satisfaction of being a parent on the Parenting Sense of Competence (PSOC) at month 2.
PSOC is a self-report measure that uses 17 questions to measure how capable a caregiver feels as a parent and how satisfied they are with being a parent. Possible scores range from 17 to 102 with higher scores indicating a higher parenting sense of competency. There are no average scores or "cut-off's" for this tool. Change= (2 months sense of competence score - baseline score).
Time frame: Baseline and Month 2.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad de Granada